Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00095082
Status:
COMPLETED
Last Update Posted:
2017-01-27
First Post:
2004-10-29
Brief Title:
Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Diabetes |
| Diabetes Mellitus Type 1 |
Keywords:
| Name | View |
|---|---|
| Diabetes Mellitus Type I | View |